Results 141 to 150 of about 37,295 (243)

Small Bowel Lesions and Bleeding Risk in Hemodialysis Patients: A Narrative Review

Hemodialysis International, Volume 30, Issue 4, Page 665-678, October 2026.
ABSTRACT Background Gastrointestinal bleeding is very common among hemodialysis patients. This high bleeding risk is caused by uremic platelet dysfunction, vascular fragility, intradialytic hemodynamic instability, and widespread antithrombotic therapy.
Andreas Smyrlis, Konstantia Kantartzi, Konstantinos Mimidis, Stylianos Panagoutsos   +3 more
wiley   +1 more source

Chemoimmunotherapy‐associated CD20 (MS4A1) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

HemaSphere, Volume 10, Issue 10, October 2026.
Alberto Guijosa, Nickolas Tsakmaklis, Sirano Dhe‐Paganon, Filip Garbicz, Ruben Carrasco, John Hatcher, Andres Ramirez‐Gamero, Dominic Pizzarella, Amanda Kofides, Shirong Liu, Hao Sun, Xia Liu, María L. Guerrera, Andrew R. Branagan, Gottfried von Keudell, Shayna R. Sarosiek, Jorge J. Castillo, Zachary R. Hunter, Steven P. Treon   +18 more
wiley   +1 more source

The rabbit thalidomide embryopathy.

, 1966
This report, of an animal model for limb changes consequent upon maternal ingestion of Thalidomide, followed the discovery and demonstration, by the authors, of a mammalian model of Thalidomide, discovered in the author's and Dr T.H.
Vickers, T.H., Pearn, John H.
core  

Cumulative thalidomide exposure, peripheral neuropathy, and clinical outcomes in pediatric and very early-onset inflammatory bowel disease: a retrospective cohort study. [PDF]

Clinics (Sao Paulo)
Mao J, Li P, Chen Z, Cao Z, Yang L, Li Z, Wang Z, Liang S.   +7 more
europepmc   +1 more source

The Thalidomide Lesson [PDF]

Science, 1962
openaire   +2 more sources

Eucalyptus camaldulensis leaf extract enhances thalidomide efficacy in acute myeloid leukemia cells through modulation of mitochondrial energetics. [PDF]

BMC Complement Med Ther
Ismail SE, Hassan AA, Elkhedel AA, Fakhry AM, Khalifa EA, Toto SM.   +5 more
europepmc   +1 more source

Chidamide-maintained long-term clinical remission with persistent T-Cell clone in refractory T-LGL leukemia-associated pure red cell aplasia: A six-year follow-up. [PDF]

Leuk Res Rep
Tao H, Jiang N, Jia Y.
europepmc   +1 more source

Design, Synthesis, Biological Studies and Putative Binding Mode of Novel Benzotriazolothalidomide Derivatives as Cereblon Ligands. [PDF]

Chem Biol Drug Des
Ganguly P, Kundu M, Sarkar T, Dcosta G, Banerjee K, Banerjee R, Hajra AK, Sahabuddin S, Basu S, Das A, Das S, Barik R, Ali MA.   +12 more
europepmc   +1 more source

Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial. [PDF]

J Hum Immun
Kawai T, Sako M, Arai K, Ishikawa T, Toma T, Wada T, Yada Y, Ishimura M, Doi T, Okada S, Moritake H, Izawa K, Ueki M, Inoue E, Nakamura H, Onodera M.   +15 more
europepmc   +1 more source

Thalidomide is not a mutagen [PDF]

Nature, 1997
openaire   +2 more sources